TANK, PPIA, ARHGAP17, CENPN, DSC2, MAF1, SLMAP, NCOA6, MED24, RCCD1, and HNRNPA2B1 that experience alterations must be specifically examined as they may be related to the advancement of breast cancer (Figure 4E). This evidence concerns the gene TANK and breast carcinoma.